Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens

被引:69
作者
Bubendorf, Lukas [1 ]
Lantuejoul, Sylvie [2 ,3 ]
de langen, Adrianus J. [4 ]
Thunnissen, Erik [5 ]
机构
[1] Univ Basel, Inst Pathol, Basel, Switzerland
[2] UNICANCER, Ctr Leon Berard, Dept Biopathol, Lyon, France
[3] Grenoble Alpes Univ, CNRS 5309, INSERM, Inst Adv Biosci,U1209, Grenoble, France
[4] Vrije Univ Amsterdam Med Ctr, Dept Resp Dis, Amsterdam, Netherlands
[5] Vrije Univ Amsterdam Med Ctr, Dept Pathol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands
关键词
IN-SITU HYBRIDIZATION; MOLECULAR TESTING GUIDELINE; OF-AMERICAN-PATHOLOGISTS; ALK GENE REARRANGEMENT; ROS1; REARRANGEMENTS; PHASE-III; ONCOGENE MUTATIONS; PD-L1; EXPRESSION; CANCER PATIENTS; OPEN-LABEL;
D O I
10.1183/16000617.0007-2017
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The pathological and molecular classification of lung cancer has become substantially more complex over the past decade. For diagnostic purposes on small samples, additional stains are frequently required to distinguish between squamous cell carcinoma and adenocarcinoma. Subsequently, for advanced nonsquamous cell nonsmall cell lung carcinoma (NSCLC) patients, predictive analyses on epidermal growth factor receptor, anaplastic lymphoma kinase and ROS1 are required. In NSCLCs negative for these biomarkers, programmed death ligand-1 immunohistochemistry is performed. Small samples (biopsy and cytology) require " tissue" management, which is best achieved by the interaction of all physicians involved.
引用
收藏
页数:15
相关论文
共 124 条
[1]   ALK Rearrangement in a Large Series of Consecutive Non-Small Cell Lung Cancers [J].
Ali, Greta ;
Proietti, Agnese ;
Pelliccioni, Serena ;
Niccoli, Cristina ;
Lupi, Cristiana ;
Sensi, Elisa ;
Giannini, Riccardo ;
Borrelli, Nicla ;
Menghi, Maura ;
Chella, Antonio ;
Ribechini, Alessandro ;
Cappuzzo, Federico ;
Melfi, Franca ;
Lucchi, Marco ;
Mussi, Alfredo ;
Fontanini, Gabriella .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (11) :1449-1458
[2]   Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT) [J].
Barlesi, Fabrice ;
Mazieres, Julien ;
Merlio, Jean-Philippe ;
Debieuvre, Didier ;
Mosser, Jean ;
Lena, Herve ;
Ouafik, L'Houcine ;
Besse, Benjamin ;
Rouquette, Isabelle ;
Westeel, Virginie ;
Escande, Fabienne ;
Monnet, Isabelle ;
Lemoine, Antoinette ;
Veillon, Remi ;
Blons, Helene ;
Audigier-Valette, Clarisse ;
Bringuier, Pierre-Paul ;
Lamy, Regine ;
Beau-Faller, Michele ;
Pujol, Jean-Louis ;
Sabourin, Jean-Christophe ;
Penault-Llorca, Frederique ;
Denis, Marc G. ;
Lantuejoul, Sylvie ;
Morin, Franck ;
Quan Tran ;
Missy, Pascale ;
Langlais, Alexandra ;
Milleron, Bernard ;
Cadranel, Jacques ;
Soria, Jean-Charles ;
Zalcman, Gerard .
LANCET, 2016, 387 (10026) :1415-1426
[3]   The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma [J].
Betz, Bryan L. ;
Dixon, Catherine A. ;
Weigelin, Helmut C. ;
Knoepp, Stewart M. ;
Roh, Michael H. .
CANCER CYTOPATHOLOGY, 2013, 121 (09) :489-499
[4]   EGFR and KRAS Mutations in Lung Carcinoma Molecular Testing by Using Cytology Specimens [J].
Billah, Shahreen ;
Stewart, John ;
Staerkel, Gregg ;
Chen, Su ;
Gong, Yun ;
Guo, Ming .
CANCER CYTOPATHOLOGY, 2011, 119 (02) :111-117
[5]   p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma [J].
Bishop, Justin A. ;
Teruya-Feldstein, Julie ;
Westra, William H. ;
Pelosi, Giuseppe ;
Travis, William D. ;
Rekhtman, Natasha .
MODERN PATHOLOGY, 2012, 25 (03) :405-415
[6]   Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology Platform Lungscape Project [J].
Blackhall, Fiona H. ;
Peters, Solange ;
Bubendorf, Lukas ;
Dafni, Urania ;
Kerr, Keith M. ;
Hager, Henrik ;
Soltermann, Alex ;
O'Byrne, Kenneth J. ;
Dooms, Christoph ;
Sejda, Aleksandra ;
Hernandez-Losa, Javier ;
Marchetti, Antonio ;
Savic, Spasenija ;
Tan, Qiang ;
Thunnissen, Erik ;
Speel, Ernst-Jan M. ;
Cheney, Richard ;
Nonaka, Daisuke ;
de Jong, Jeroen ;
Martorell, Miguel ;
Letovanec, Igor ;
Rosell, Rafael ;
Stahel, Rolf A. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) :2780-+
[7]   Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].
Borghaei, H. ;
Paz-Ares, L. ;
Horn, L. ;
Spigel, D. R. ;
Steins, M. ;
Ready, N. E. ;
Chow, L. Q. ;
Vokes, E. E. ;
Felip, E. ;
Holgado, E. ;
Barlesi, F. ;
Kohlhaeufl, M. ;
Arrieta, O. ;
Burgio, M. A. ;
Fayette, J. ;
Lena, H. ;
Poddubskaya, E. ;
Gerber, D. E. ;
Gettinger, S. N. ;
Rudin, C. M. ;
Rizvi, N. ;
Crino, L. ;
Blumenschein, G. R. ;
Antonia, S. J. ;
Dorange, C. ;
Harbison, C. T. ;
Finckenstein, F. Graf ;
Brahmer, J. R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639
[8]   ROS1 Immunohistochemistry Among Major Genotypes of Non-Small-Cell Lung Cancer [J].
Boyle, Theresa A. ;
Masago, Katsuhiro ;
Ellison, Kim E. ;
Yatabe, Yasushi ;
Hirsch, Fred R. .
CLINICAL LUNG CANCER, 2015, 16 (02) :106-111
[9]   ALK and ROS1 Rearrangements Tested by Fluorescence In Situ Hybridization in Cytological Smears From Advanced Non-Small Cell Lung Cancer Patients [J].
Bozzetti, Cecilia ;
Nizzoli, Rita ;
Tiseo, Marcello ;
Squadrilli, Anna ;
Lagrasta, Costanza ;
Buti, Sebastiano ;
Gasparro, Donatello ;
Zanoni, Daniele ;
Majori, Maria ;
De Filippo, Massimo ;
Mazzoni, Francesca ;
Maddau, Cristina ;
Naldi, Nadia ;
Sammarelli, Gabriella ;
Frati, Caterina ;
Pinto, Carmine ;
Ardizzoni, Andrea .
DIAGNOSTIC CYTOPATHOLOGY, 2015, 43 (11) :941-946
[10]   ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA [J].
Bravaccini, S. ;
Tumedei, M. M. ;
Ulivi, P. ;
Zoli, W. ;
Calistri, D. ;
Candoli, P. ;
Amadori, D. ;
Puccetti, M. .
CYTOPATHOLOGY, 2016, 27 (02) :103-107